Browsing Tag
Canaccord Genuity
26 posts
System1 Group rejects Brave Bison bid as market values SYS1 above the offer
System1 Group has formally rejected Brave Bison Group’s unsolicited takeover offer, with more than 21% of shareholders indicating they currently do not intend to accept and the market itself valuing SYS1 above the implied bid price.
Titomic (ASX: TTT) locks in A$16.5m placement at 23.5% discount to fund 2027 breakeven
Titomic has secured A$16.5 million from institutional investors to expand its Huntsville manufacturing base and fund operations through management's projected 2027 cash-flow breakeven point. The placement increases the existing share count by approximately 7.9% and is priced at a steep 23.5% discount to the last traded price.
Yellow Wood is paying $1bn for supplement brands producing $1.2bn of sales, but the missing number is profit
Yellow Wood Partners is acquiring Nature’s Bounty, Osteo Bi-Flex, Puritan’s Pride and four other supplement brands from Nestlé for $1 billion, even though the portfolio generated $1.2 billion of 2025 sales. The roughly 0.83-times revenue price contrasts sharply with the premium Nestlé paid when it expanded aggressively into supplements five years ago, although the asset packages are not directly comparable. Private equity is now betting that mature health brands can grow faster outside the Swiss conglomerate.
Docebo (DCBO) launches US$70m issuer bid as preliminary Q2 revenue exceeds prior guidance
Docebo plans to cancel as much as 13.8% of its stock through a largely debt-funded issuer bid while raising its 2026 revenue outlook.
System1 (AIM: SYS1) reiterates rejection of Brave Bison’s (AIM: BBSN) £43.1m takeover proposal
The target’s recovering second-half performance and debt-free balance sheet are colliding with Brave Bison’s argument that combining the companies would create a larger marketing technology platform.
Bravura Solutions (ASX: BVS) jumps 15% as FY26 EBITDA upgrade tests AIM rerating
Bravura Solutions rallied after lifting FY26 cash EBITDA to A$77m. August results must prove whether BVS has durable recurring growth.
Invinity Energy Systems wins 32 MWh US steel mill battery deal as IES stock falls
Find out how Invinity’s 32 MWh California battery deal could reshape IES stock, US steel decarbonisation and long-duration storage demand.
Beeks Financial Cloud stock gains AI edge as BKS secures third Market Edge contract
Find out how Beeks Financial Cloud’s $10m June contract run and Market Edge Intelligence wins could reshape BKS stock and exchange tech demand.
Corcept Therapeutics (NASDAQ: CORT) climbs 7% as Lifyorli launch and analyst upgrades drive cortisol re-rating
Corcept turned a stress hormone into an ovarian cancer drug. Lifyorli is launching fast and analysts are chasing, but a premium multiple prices in a lot.
Intuitive Machines (NASDAQ: LUNR) surges 11% on Cantor upgrade and Lunar Terrain Vehicle catalyst
Intuitive Machines ran 80% on a Cantor upgrade and a pending NASA contract. But the rover award just went to rivals, and the stock trades at 39x sales.